HP and stomach disorder: A previous clinical study in Beijing, incorporating Hp-sATT qualitative analysis, suggested that the consistency between the Hp-sATT and 13C-UBT was moderate (Kappa = 0.52), and the consistency between the Hp-sATT and SS-Hp was poor (Kappa = 0.30), with Type I Hp infection leading to more obvious gastric diseases [32], but the impact of Hp eradication treatment on serological antibodies was not considered.